Cannabidiol (CBD)

Most pharmacists are moderately to not-at-all comfortable answering patient questions about cannabis. That needs to change.

A recent review expounded the effects that cannabidiol may be having on cognition in patients with epilepsy.

Investigators supplemented a slim body of existing research on CBD for pain management.

Co-principal investigators Jeff Lombardo and Keith Aqua discuss the unique patient profiles of the study, future cohorts, and FDA's response to the findings.

Pharmacists interested in driving profit through CBD can start by changing their mindset.

Selling CBD can be profitable for pharmacies, if they follow regulatory guidelines.

How to discuss CBD and answer questions frequently asked by patients

Jason Mitchell, board-certified naturopathic doctor, co-founder and CEO of HempFusion Wellness Inc, dives into the world of cannabinoids and what's on the horizon for CBD.

OTC CBD is often touted for its uses in pain management, anxiety relief, and sleep. But the popular cannabinoid has been shown to benefit women’s health, too––an opportunity that pharmacies can leverage as a cash-based revenue strategy.

Although nearly 70% of the population cohort had conditions requiring medications, there was no increase in the number of reported adverse events while taking CBD products.

BioLyte Laboratories and Honest Globe have 15 days to rectify the violations from their CBD products.

In a presentation from APhA2021, clinical pharmacist Danielle Fixon, PharmD, BCGP, BCPS, offers counseling tips for CBD products.

Results of a study presented in a poster presentation during ASHP Midyear collected data of the available OTC CBD products being sold in Colorado pharmacies.

Survey results presented during the ASHP 2020 Midyear Clinical Meeting and Exhibition offered insight into community pharmacists’ knowledge and confidence of CBD products.

Although the booming demand can make CBD products a profitable addition to any pharmacy inventory, some questions remain about the legal compliance factors.

Tips for building financial success with CBD for your pharmacy.

As the use of CBD-containing products continues to rise, pharmacists need to be familiar with the clinical implications of CBD use, especially in patients who use other pharmacologically active substances.

What pharmacists need to consider before selling CBD in their stores.

By 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.

CBD and its impacts on a protective peptide show that the cannabinoid may reduce lung inflammation and damage.

The FDA approved a cannabidiol oral solution treatment (Epidiolex, Greenwich Biosciences) for seizures associated with tuberous sclerosis complex.

Our first episode of our latest Cannabis Series is focused on the burgeoning medical marijuana landscape, featuring FDA's guidelines and research on the diverse benefits of cannabis as medicine.

Responding to growing interest by industry stakeholders, the agency has offered draft guidance outlining quality considerations and other practical recommendations for cannabis and cannabis-derived compounds.

A systematic review of medical cannabis and cannabinoid use in oncology care demonstrated varied results. 

Cannabidiol oral solution (Epidiolex, GW Pharmaceuticals) is no longer considered a controlled substance.